Skip to content

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

variable

Daewoong Pharmaceutical’s “‘Hoystar tablet’ could not meet the main evaluation variable in phase 2a clinical trial for corona treatment”

Daewoong Pharmaceutical’s “‘Hoystar tablet’ could not meet the main evaluation variable in phase 2a clinical trial for corona treatment”

Daewoong Pharmaceutical’s Hoy Star tablet phase 2a main evaluation variable not satisfied…2b/3 phase progress

Daewoong Pharmaceutical’s Hoy Star tablet phase 2a main evaluation variable not satisfied…2b/3 phase progress

Newer posts
← Previous Page1 … Page3 Page4

footer

  • Contact Us
  • Sitemap
  • News-Sitemap
© 2025 Aju.News/en